secwatch / observer
8-K filed November 12, 2021, 6:59 PM ET ticker NOVT CIK 0001076930
leadership confidence high sentiment neutral materiality 0.30

Director Deborah DiSanzo resigns from Novanta board effective Feb 28, 2022

NOVANTA INC

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Deborah DiSanzo

Director
NOVT · NOVANTA INC
Effective
2022-02-28
Filed
November 12, 2021, 6:59 PM ET
On November 6, 2021, Deborah DiSanzo, a member of the Board of Directors (the “Board”) of Novanta Inc. (the “Company”), informed the Company of her decision to resign from the Board, effective February 28, 2022, in order to focus her attention on her responsibilities as the President of Best Buy Health and other professional responsibilities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Deborah DiSanzo resigned as Director at NOVANTA INC.

Action
resigned
Role
Director
Exact text from the filing
On November 6, 2021, Deborah DiSanzo, a member of the Board of Directors (the “Board”) of Novanta Inc. (the “Company”), informed the Company of her decision to resign from the Board, effective February 28, 2022, in order to focus her attention on her responsibilities as the President of Best Buy Health and other professional responsibilities.
View on SEC.gov

NOVANTA INC filing history →

Source: SEC EDGAR
accession 0001564590-21-056708
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.